Introducing the test that assists in
speeding up your recovery.
iDNA PGx CNS: The right treatment is in our DNA
The Pharmacogenetic analysis offered by iDNA PGx CNS represents a personalized approach to treating Central Nervous System disorders. This test is a useful tool that supports the physician in selecting the appropriate medication.
It provides useful data for the treatment of depression, allowing the treating doctor to tailor treatment based on the genetic characteristics of each individual.
It helps the qualified physician to select the appropriate medication and dosage for each patient, ensuring optimal response and minimizing any side effects. Through pharmacogenetic analysis, patients, with the guidance of their doctor, can find the ideal treatment for depression.
The iDNA PGx CNS is an in vitro diagnostic (IVD) medical device bearing the CE mark
Process
Easy and simple process
iDNA PGx CNS is painless, simple and fast!
To complete the procedure, a buccal swab (saliva sample) is required, which is collected with a special swab by qualified healthcare personnel.
Each DNA test, does not need to be repeated, it is done once in a lifetime.
Order
Consult your treating doctor to supply you with the Test Kit.
Collect sample
Free sample collection is provided by your doctor or at Affidea's partner Diagnostic Centres. Alternatively, home sampling is available for a fee
Registration kit
Choose between online registration or completion of documents
Sample Dispatch
Return the kit to iDNA Laboratories for FREE
Results
The result report is sent within 15 working days to you and your doctor
Medication
The personalized result report is a tool for your treating doctor for determining the appropriate medication
Affordable Solution for All
Our goal is to make iDNA PGX CNS an affordable solution accessible to all patients.
iDNA PGx CNS €140
Available only through your treating doctor
In the indication of persistent depression, the test is covered by the EOPY and a reimbursement (approx. 50%) is provided
Consult your treating physician and take your health into your own hands.
Results Report
The personalized Pharmacogenomic Report is available within 15 business days
Both you and your treating doctor receive the results report.
The content of the analysis is a tool for individualized medication selection for depression. It helps to avoid multiple medication switches until the ideal treatment is found for each patient. Gives the psychiatrist valuable information about medications that may require dose adjustment, have lower efficacy, or are associated with an increased risk of side effects based on your genetic data.
Your doctor will review these results as part of your overall evaluation, with the goal of developing a treatment plan to help you effectively manage your depression.
Your personal results report is automatically updated and sent to you and your doctor when new scientific data arises.
Precision Medicine in Depression
Has already helped patients
>3000
The patients' point of view
96%
Responded positively to personalized treatment
83%
Reported no serious side effects
90%
Reported adjustment in dosage or change in treatment scheme
87%
Reported fewer visits or communication with the treating doctor
Scientific Documentation for Pharmacogenetic Guidance
Improved quality-weighted life years of patients with moderate to severe major depressive disorder
Reduced suicides by 25% at 5 years
Led to an increase in clinical response and remission
Sources
Chatziandreou, E., & Panagiotou, N. (2022). Cost-Effectiveness Analysis of Pharmacogenetic-Guided Treatment in Drug Resistant Depression. Value in Health, 25(12), S68
Gkouvas N., et al. (2022). iDNA PGx CNS improves MDD treatment decisions and clinical outcomes: A patient case series analysis. 30th European Congress of Psychiatry
© Copyright – iDNA Laboratories | Developed by ADS Solutions
